Agnès Hincelin-Méry

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial

Juris J. Meier, Julio Rosenstock, Agnès Hincelin-Méry et al. · Diabetes Care · 2015 · 255 citations

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

Christoph Kapitza, Thomas Först, Hans Veit Coester et al. · Diabetes Obesity and Metabolism · 2013 · 189 citations · Full text

Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis

Jocelyn Quistrebert, Signe Hässler, Delphine Bachelet et al. · Seminars in Arthritis and Rheumatism · 2018 · 56 citations · Full text

Rheumatoid Disorder, Rheumatology, Epidemiology +10

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

Delphine Bachelet, Signe Hässler, Cyprien Mbogning et al. · PLoS ONE · 2016 · 40 citations · Full text

Systemic Diseases, Disease Progression, Immunodeficiencies +24

Methotrexate and BAFF interaction prevents immunization against TNF inhibitors

Samuel Bitoun, Gaëtane Nocturne, Bineta Ly et al. · Annals of the Rheumatic Diseases · 2018 · 30 citations